Why not include apixaban? I’m included a link to the #AVERT trial.
https://www.nejm.org/doi/full/10.1056/NEJMoa1814468 …
-
-
-
not sure- seems AVERT trial was for prophylaxis. the article states "Edoxaban and rivaroxaban have been studied in the setting of cancer-associated thrombosis, and a randomized trial evaluating apixaban is ongoing (https://clinicaltrials.gov/ct2/show/NCT03045406 …)"
- 2 more replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.